Cg. Willett et al., CHANGES IN TUMOR PROLIFERATION OF RECTAL-CANCER INDUCED BY PREOPERATIVE 5-FLUOROURACIL AND IRRADIATION, Diseases of the colon & rectum, 41(1), 1998, pp. 62-67
PURPOSE: This study examines the effect of 5-fluorouracil administrati
on during preoperative irradiation on rectal cancer tumor proliferatio
n. PATIENTS AND METHODS: One hundred and fifty-three patients with loc
ally advanced rectal cancer received 45 to 50 Gy of preoperative irrad
iation with (103 patients) and without (50 patients) concurrent 5-fluo
rouracil, followed by surgery. Pretreatment tumor biopsies and postirr
adiation surgical specimens were scored for proliferative activity by
assaying the extent of Ki-67 and proliferating cell nuclear antigen im
munostaining and tile number of mitoses per ten high-powered fields. P
ostirradiation specimens were also assessed for downstaging. RESULTS:
Although 5-fluorouracil did not improve downstaging rates, marked decr
eases in the activity of all three markers of proliferation (mitotic c
ounts, Ki-67, and proliferating cell nuclear antigen immunostaining) w
ere seen in rectal cancers of patients receiving the drug. No signific
ant decreases were noted in patients undergoing irradiation only. CONC
LUSION: The addition of 5-fluorouracil to preoperative irradiation res
ulted in a more complete inactivation of the proliferating population
Frequency of downstaging, however, was unaffected. Thus, the quiescent
cell population appears to represent a substantial barrier to further
downstaging. New treatment strategics should be aimed at controlled r
ecruitment of quiescent tumor cells at the time of irradiation.